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INTRODUCTION:  Over  one  million  treatments  in  more  than  40  countries  have  been  administered  Zyplast
implants.  Infections  at collagen  implant  sites  have  occurred  in  fewer  than  one per thousand  treated
patients.
PRESENTATION  OF  CASE:  We  present  a case  report  of a  27-year-old  man;  he developed  a  severe  granulo-
matous  reaction  in  the  site  of  resolvable  collagen  ﬁller  injection  Zyplast,  and  one  month  later  developed
a  cutaneous  nodular  lesion.  Histological  examination  of the  lesion  revealed  Keratoacanthoma  (KA)  with
surgical  margins  free  of  tumor.  We  performed  two surgical  corrections  within  a period  of  six  months  on
multiple  hypertrophic  skin  scars  of  the  face.  Two  years  after  the  last excision,  the  patient  continued  to
be  free  of  any  recurrence.
DISCUSSION: Keratoacanthoma  (KA)  is  a  benign  skin  tumor  with  a quick  growth  pattern  but  may  regress
spontaneously.  Though  the  exact  etiology  of  KA  is  uncertain,  it  is  found  to  be  more  frequent  in elderly
people,  on  photo-exposed  skin  areas  and  cutaneous  infection  site.  Bovine  collagen  intradermal  injections,
though  catabolized  over  the  time  in the  patient,  can raise  several  complications  already  described  in
technical  literature,  but we want  underline  that  cutaneous  infection  near  ﬁller  injection  site  can  develope
KA as  described  in  our  case  report.
CONCLUSION:  KA  must  be  considered  as  a new  local  unforeseeable  complication  of bovine  collagen  injec-
tion  to  ﬁll  facial  soft  tissue  when  occurred  a face  cutaneous  infection.  We  believe  that radical  excision  is
the golden  standard.
gical © 2013 Sur
. Introduction
Over one million treatments in more than 40 countries have
een administered Zyplast implants. Rigorous clinical trials, to
etermine the safety and efﬁcacy of Zyplast collagen implants, were
onducted from 1976 to 1981. This data was submitted to the Food
nd Drug Administration and Zyplast implants were cleared for
arketing in 1981 and 1985 respectively. Collagen implants are
ndicated for the correction of contour deﬁciencies of soft tissue,1
ainly as ﬁller for facial imperfections. A collagen implant is a
terile device composed of highly puriﬁed bovine dermal colla-
en that is lightly cross-linked with glutaraldehyde.2 They have
een employed successfully in many areas of the body to correct
istensible acne scars, atrophy from disease or trauma, glabellar
rown lines, nasolabial folds, or defects due to rhinoplasty, skin
raft or other surgery, and other soft tissue defects.1 Four weeks
rior to the procedure, Collagen Test Implant is injected intrader-
ally into the volar forearm to determine if a patient demonstrates
ensitivity to the implants. Laboratory results have shown that
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ninety-seven percent of men  and women tested can be treated with
Zyplast implants.2 Collagen implant therapy must not be initiated
if the patient has a positive response to the required Collagen Test
Implant.1
2. Presentation of case
This case report describes a 27 year-old, caucasian patient, who
developed a skin nodule in sites of the Zyplast ﬁller injections
one month post treatment. The young patient resulted negative
in the Collagen Implant Test. About one month after the implant
test, he began the Zyplast injections. Seven months after the injec-
tion, the patient was  submitted to another injection of the same
bovine collagen to increase his soft facial tissue. Eight days after the
last injection ﬁller, the young patient developed an inﬂammatory
reaction of the soft facial tissue along with edema and pain syn-
drome. He developed an inﬂammatory reaction in all injected sites
simultaneously. The systemic symptoms resolved after 20 days of
anti-inﬂammatory and antibiotic therapy.
Open access under CC BY-NC-ND license.A physical examination 30 days after the last injection of the
ﬁller showed: circular nodular skin lesion (thickness 0.6 cm)  diam-
eter 4.5 cm,  in the right nasolabial fold; irregular nodular skin lesion
with important edema, in right maxilla region; ellipsoidal nodular
Y-NC-ND license.
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Fig. 1. Left side view of the face of 27 year-old Caucasian patient after injection of
bovine collagen 30 days after the second injection of the ﬁller.
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tFig. 2. Scars of face of patient after 2 years.
kin lesion (thickness 1 cm), diameter 5 cm,  in the left nasolabial
old; circular nodular skin lesion, diameter 1.2 cm,  in left maxilla
egion (Fig. 1). After two months, another nodular lesion devel-
ped in the right cheek. This nodule was excised with wide margins.
istological examination of the lesion revealed Keratoacanthoma
KA) with surgical margins free of tumor. After 2 years the patient
as recovered into our department. The physical examination of
he face showed (Fig. 2): hypertrophic irregular scar in right cheek
ear nasolabial fold (Fig. 3), hypertrophic scar in right maxilla
egion, hypertrophic irregular scar in left cheek near nasolabial
old, atrophic linear scar in left maxilla region. We  performed two
urgical corrections within a period of six months on multiple
ypertrophic skin scars of the face. Two years after the last excision,
he patient continued to be free of any recurrence (Fig. 4).Fig. 3. Particular of right side face view after 2 years.Fig. 4. Face of patient after 3 years to the plastic reconstructive surgery.
3. Discussion
With the increase in products available and the rise in the num-
ber of patients seeking this type of intervention, it is crucial that
both the physician and the patient are fully aware of the risks
involved with each product. Adverse reactions to bovine collagen
implants occur in a small percentage of treated patients. These reac-
tions resolve, for the most part, with time as the host reabsorbs
the implant material.3 Sometimes these reactions take weeks to
months to develop after the injections, and may  result in indura-
tion and/or scar formation. Also, in less than one in 1000 treated
patients, systemic complaints consisting of nausea, rash, headache,
joint aches, or difﬁculty in breathing have been reported.9 Bovine
collagen intradermal injections, though catabolized over the time
in the patient, can raise several complications already described in
technical literature, but we  want underline that KA can be consid-
ered as a new local complication of bovine collagen injection to ﬁll
facial soft tissue when occurred a face cutaneous infection in site
of injection in some patient, as dimostreted in this case report. All
patients who want to undergo this treatment must be previously
informed about any possible, permanent complications they could
run into, but above all that clinical experience with injectable col-
lagen implants was not available prior to 1976, and the safety of
this product for a longer duration is not known.1
Infections at collagen implant sites have occurred in fewer
than one per thousand treated patients, and reactivation of a
pre-existing herpes simplex infection at implantation sites has
been reported in fewer than one per ten thousand patients. These
responses resolved quickly and without sequelae.1 These reactions
take weeks to months to develop after the injections and may
result in induration and/or scar formation. Local necrosis is a rare
event, which has been observed following collagen implantation.
Most necroses reported through post-marketing surveillance have
occurred in the glabella.1 Systemic complaints have been reported
by fewer than 0.5% of collagen implant patients.1 As a result, two
rounds of skin testing are required adding inconvenience and delay
for both the practitioner and patient. Furthermore, a negative skin
test does not guarantee allergic reactions or other more serious side
effects will not occur.3
KA is a skin tumor that typically presents with a history of rapid
growth over a short period of time in people aged 50 and older.
Sir Jonathan Hutchinson ﬁrst described it in 1889 as “crateriform
ulcer of the face”.4 Rapid growth over a period of 1–2 months, size of
1–2 cm,  and spontaneous involution after 3–6 months is typical.5Etiology of this tumor is controversial. The theory that KA of the
skin and well-differentiated squamous cell carcinoma are part of
the same disease entity is not new.6 In the before literature, a lot of
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ublications show the arising of KA after sun exposure, UVB pho-
otherapy, radiotherapy, cryotherapy, cutaneous infection site, and
mmunosuppressive virus, but in recent years there has been an
ncreasing number of reports of KA arising at sites of trauma.7 A
ausal relationship between keratoacanthoma and a variety of pre-
eding traumatic events has been postulated in the literature.8 We
elieve that an early complete excision is the treatment of choice
or all skin neoplasms supposed to be KA.
. Conclusion
We are in agreement with the new Zyplast’s “collagen implant
hysician package insert”, concerning the use of ﬁller upon exam-
nation only at least two “collagen test implant” to evaluate
ompatibility with patients who have never experienced bovine
ller. We  suggest at least one more compatibility test should be
erformed before every treatment for all patients formerly treated
ith this ﬁller. It is reasonable to prophylaxis subject the patient
o antibiotic after ﬁller injection. Our patient was atypical for his
oung age and the circumstances that produced his KA. We  sup-
ose that intense exposure to inﬂammatory stimulus by cutaneous
nfection in the sites of collagen injection predisposes the devel-
pment of KA. We  propose radical excision of a KA developed in
he infected site injection of cosmetic ﬁller. The result of the surgi-
al reconstructions in this young man  has deﬁnitely improved the
atient’s condition, though the patient is certainly dissatisﬁed with
he indelible signs on his face from the local complicated adverse
eaction to the resorbable ﬁller.
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